ikool

    • ikoolikool
      ·09-09
      $BitMine Immersion Technologies Inc.(BMNR)$ September 9th, BitMine's Board Chairman Tom Lee posted on social media that as part of BitMine's \"Lunar Landing Plan\" strategy, Bitmine (BMNR) acquired 13 million shares of OCTO at a price of $1.46 per share, with a total investment of $20 million. At the time of writing, Eightco Holdings (OCTO) surged by 4834.83% intraday, with a stock price of $71.56, an increase of $70.1 for the day. This means that Bitmine's 13 million shares of OCTO are currently worth $960 million, with a paper profit of $940 million in this OCTO investment transaction. Excerpt..waiting.. 🤑🤑🤑
      861Comment
      Report
    • ikoolikool
      ·06-16
      my pick for stock that will grow 10x is @CRCL. General Adoption.
      1.07KComment
      Report
    • ikoolikool
      ·05-02
      Any legal challenge on CNBC on fake news to lower Tesla stock price?
      Sorry, this post has been deleted
      1.54KComment
      Report
    • ikoolikool
      ·03-10
      Will it be delisted?
      Sorry, this post has been deleted
      1.25KComment
      Report
    • ikoolikool
      ·2024-11-16
      You Gave Us Hope. THANK YOU

      CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar

      CERo Therapeutics Holdings said Friday that the US Food and Drug Administration has cleared its investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.The company said it expects to start the phase 1 trial in Q1 of 2025.CERo's shares soared past 79% in recent trading.Price: 0.34, Change: +0.15, Percent Change: +79.22
      CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar
      2.17KComment
      Report
    • ikoolikool
      ·2024-11-16
      A new era in mankind against deadly diseases, deserves our bullish and encouraging support. FOR ALL MANKIND

      CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar

      CERo Therapeutics Holdings said Friday that the US Food and Drug Administration has cleared its investigational new drug application for a phase 1 trial of its lead compound CER-1236 to treat acute myelogenous leukemia.The company said it expects to start the phase 1 trial in Q1 of 2025.CERo's shares soared past 79% in recent trading.Price: 0.34, Change: +0.15, Percent Change: +79.22
      CERo Says US FDA Clears Investigational New Drug Application to Launch Leukemia Treatment Trial; Shares Soar
      2.35KComment
      Report
    • ikoolikool
      ·2024-11-15
      Trump not aware on report o axe EV credtits.
      2.37KComment
      Report
    • ikoolikool
      ·2024-10-01
      $Fangdd Network Group(DUO)$ China major property relationship Comapny sees explosives growth from recent China financial incentives policy..BULLISH$$$$$$$
      2.46KComment
      Report
    • ikoolikool
      ·2024-09-10
      $China Mining(BHD.SI)$ 🤑🤑🤑HOZL
      1.80KComment
      Report
    • ikoolikool
      ·2024-08-31
      $NVIDIA Corp(NVDA)$  Holtz.. weekends surprises..
      2.30KComment
      Report
       
       
       
       

      Most Discussed